Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Boehringer Ingelheim
Merck
AstraZeneca
McKinsey

Last Updated: January 21, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Biapenem


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Biapenem?

Biapenem is an investigational drug.

There have been 4 clinical trials for Biapenem. The most recent clinical trial was a Phase 1 trial, which was initiated on January 1st 2017.

The most common disease conditions in clinical trials are Bacterial Infections, Neoplasm Metastasis, and [disabled in preview]. The leading clinical trial sponsors are Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company), Alphacait, LLC, and Haining Health-Coming Biotech Co., Ltd.

There are eight hundred and eighty US patents protecting this investigational drug and five international patents.

Recent Clinical Trials for Biapenem
TitleSponsorPhase
Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid TumorAlphacait, LLCPhase 2
Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid TumorHaining Health-Coming Biotech Co., Ltd.Phase 2
Safety Study of Intravenous Biapenem (RPX2003) and RPX7009 Given Alone and in CombinationRempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company)Phase 1

See all Biapenem clinical trials

Clinical Trial Summary for Biapenem

Top disease conditions for Biapenem
Top clinical trial sponsors for Biapenem

See all Biapenem clinical trials

US Patents for Biapenem

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Biapenem ⤷  Try it Free Small molecules for the modulation of MCL-1 and methods of modulating cell death, cell division, cell differentiation and methods of treating disorders Dana-Farber Cancer Institute, Inc. (Boston, MA) ⤷  Try it Free
Biapenem ⤷  Try it Free Cyclic boronic acid ester derivatives and methods of making the same Rempex Pharmaceuticals, Inc. (San Diego, CA) ⤷  Try it Free
Biapenem ⤷  Try it Free Methods of treating inflammation associated airway diseases and viral infections WASHINGTON STATE UNIVERSITY (Pullman, WA) THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (Austin, TX) ⤷  Try it Free
Biapenem ⤷  Try it Free Anionic-core composition for delivery of therapeutic agents, and methods of making and using the same PharmaIN Corporation (Bothell, WA) ⤷  Try it Free
Biapenem ⤷  Try it Free Inhibitors of metallo-.beta.-lactamase-enzymes McMaster University (Hamilton, CA) ⤷  Try it Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Biapenem

Drugname Country Document Number Estimated Expiration Related US Patent
Biapenem Australia AU2011210567 2030-01-29 ⤷  Try it Free
Biapenem Canada CA2787784 2030-01-29 ⤷  Try it Free
Biapenem European Patent Office EP2528893 2030-01-29 ⤷  Try it Free
Biapenem European Patent Office EP3138838 2030-01-29 ⤷  Try it Free
Biapenem Japan JP2013518816 2030-01-29 ⤷  Try it Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Boehringer Ingelheim
Merck
AstraZeneca
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.